Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

Real world study examined the effectiveness and safety of CAR T therapy tisagenlecleucel for treatment of relapsed diffuse large b-cell lymphoma.